Virbac SA banner

Intrinsic Value

Is V16 undervalued or overvalued?

See the intrinsic value estimate for Virbac SA and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

V16 Intrinsic Value
LOCKED
Unlock
Today vs. history

V16 looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with V16’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor V16
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Current Price €342.5
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to V16

Fundamental Analysis

What Virbac Does

Pharmaceuticals Health Care

Virbac SA is an animal health company. It makes and sells medicines, vaccines, diagnostic products, and other care products for pets and farm animals. Its lineup includes treatments for parasites, skin and ear conditions, vaccines, and veterinary nutrition products.

Headquarters
France FR
Employees
6 442
IPO date
Jan 1, 1985
Read the full company overview
View Company Overview

Virbac has no economic moat

No Moat Narrow Wide

Virbac SA lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
Virbac SA

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one V16 stock?

The intrinsic value for Virbac SA (V16) under the Base Case is hidden EUR.

Is V16 stock undervalued or overvalued?

Compared with the current market price of 342.5 EUR, the stock appears hidden.

Back to Top